Novanta (NOVT) Scheduled to Post Earnings on Tuesday

Novanta (NASDAQ:NOVT) will be issuing its quarterly earnings data before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.57 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Novanta (NASDAQ:NOVT) last posted its earnings results on Wednesday, February 28th. The technology company reported $0.63 earnings per share for the quarter, meeting the consensus estimate of $0.63. The business had revenue of $211.60 million during the quarter, compared to the consensus estimate of $210.90 million. Novanta had a return on equity of 17.15% and a net margin of 8.27%. The business’s quarterly revenue was down 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.75 EPS. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Trading Up 0.2 %

NASDAQ:NOVT opened at $159.89 on Friday. The company has a market capitalization of $5.73 billion, a PE ratio of 78.76 and a beta of 1.35. Novanta has a 52-week low of $111.20 and a 52-week high of $187.60. The stock’s 50 day moving average price is $166.82 and its 200 day moving average price is $156.99. The company has a quick ratio of 1.91, a current ratio of 2.98 and a debt-to-equity ratio of 0.52.

Insider Activity

In other Novanta news, CEO Matthijs Glastra sold 5,000 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $172.00, for a total transaction of $860,000.00. Following the transaction, the chief executive officer now directly owns 24,572 shares of the company’s stock, valued at approximately $4,226,384. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Robert Buckley sold 1,500 shares of Novanta stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $160.23, for a total value of $240,345.00. Following the transaction, the chief financial officer now directly owns 120,159 shares in the company, valued at approximately $19,253,076.57. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Matthijs Glastra sold 5,000 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $172.00, for a total transaction of $860,000.00. Following the completion of the transaction, the chief executive officer now directly owns 24,572 shares in the company, valued at $4,226,384. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 9,500 shares of company stock valued at $1,611,545. 1.20% of the stock is currently owned by company insiders.

Novanta Company Profile

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.